Esther Pungolino

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Therapeutic approach for chronic myeloid leukemia (CML) patients has undergone a revolutionary change with the introduction of tyrosine kinase inhibitors, which improved overall survival and quality of life. Optimal therapy adherence has become of paramount importance to maximize the benefits in the long-term outcome. Several evidences have been reported(More)
  • 1